Background: In the preterm newborn, a packed red blood cell (PRBC) transfusion results in a pro-inflammatory response termed transfusion related immunomodulation (TRIM). Pretransfusion washing of PRBCs may abrogate or minimise TRIM. In adults and paediatric patients, transfusions with washed blood decreases pro-inflammatory cytokine production, morbidity and mortality. Whether a transfusion with washed blood similarly benefits the neonatal population remains unknown.
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Methods: In this double-blinded pilot, infants born <30 +0 (n=37) were randomised to receive either 'washed' or standard PRBCs for their first transfusion exposure. Samples were collected from the pack and from infants prior and 4-6 hours posttransfusion. Pre-, post-, and transfusion pack levels of inflammatory cytokines were analysed using multiplex ELISA. Data were analysed blinded to group allocation, with blinding removed following statistical analysis.
Results: Baseline clinical characteristics were similar between the two groups, with no difference in the median postnatal age of first transfusion. Infants exposed to 'washed' blood had significantly lower post-transfusion concentrations of IL6 and TNFα (p<0.05). No differences were seen in post-transfusion concentrations of anti-inflammatory cytokines.
Conclusions: Transfusion with washed PRBCs appears to reduce the pro-inflammatory response compared to standard PRBCs. This decreased immune response may reduce the rate of transfusion related morbidities in preterm neonates. This pilot RCT has identified a biologically plausible mechanism of how washed PRBCs may reduce TRIM. These results highlight the potential of this practise to improve neonatal morbidity rates, and strongly supports the development of a large multi-centre RCT comparing transfusion of washed to standard PRBCs on neonatal clinical outcomes. Background: In individual studies maternal supine going-tosleep position is reported to increase the risk of late stillbirth (≥28 week) 2.3 to 6.2 fold compared to left side position. We aimed to: 1) confirm the relationship between going-to-sleep position and late stillbirth risk and 2) test for interactions between sleep position and indicators of fetal vulnerability (small for gestational age [SGA] , maternal smoking, and obesity).
Methods: We searched publications identified by systematic bibliographic searches for studies that collected data on: women with late stillbirth and pregnant controls matched for gestation, and late pregnancy sleep position with no sleep position intervention. One-step meta-analysis of individual participant data using mixed-effects models was performed.
Results: We identified data from four case-control studies (cases, n=713 late stillbirths; controls, n=1804). Pooled adjusted odds ratio [aOR] for supine going-to-sleep position compared to left side was 3.35 (95% confidence interval [CI] 2.29 to 4.9), and for right side, 1.11 (95% CI 0.89 to 1.38) compared to left side. There was no significant interaction between supine going-to-sleep position and maternal obesity (p=0.10), smoking (p=0.52), or SGA (p=0.21).
Conclusions: As there was no interaction with measures of vulnerability, supine going-to-sleep position can be considered a risk factor for late stillbirth in all pregnancies, with no difference in fetal outcome risk between left and right side going-to-sleep position for women in the third trimester. Mater Mothers' Hospital, South Brisbane, Australia
Background: The SuPreme study involves measuring plasma sulphate levels in 1,505 preterm infants (<32wks gestation) at 1wk of age and testing the hypothesis that sulphate level inversely correlates with adverse neurodevelopment outcome. This study is important for understanding the neuroprotective benefit of antenatal magnesium sulphate (MgSO 4 ) which is currently attributed to the magnesium content, even though sulphate is important for modulating brain development.
Methods: Prospective study recruiting preterm infants in Brisbane at MMH and RBWH. Plasma sulphate levels measured using ion chromatography, and genes that mediate sulphate transfer in
